Psychiatric treatment is undergoing a profound shift as once-stigmatized psychedelic drugs…
Category: Clinical Trials
Home / Clinical Trials / Page 2
Adding to research suggesting that vaccines for certain viral diseases may make someone…
Following 30 years of research and development, the first malaria vaccine…
Recent advancements have led to the development of new cancer therapies…
A recent Phase III clinical trial found that lecanemab reduces cognitive…
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™…
In 2018 the word “hangry,” the portmanteau of hungry and angry,…
Russia’s invasion of Ukraine is causing what the Financial Times called…
Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including…
When designing pediatric clinical drug trials, it’s important to work with…
Children are not little adults, but due to a lack of…
In the pharmaceutical and biotechnology industry more small and even virtual…
Did you know that only about 20 percent of drugs used…
Shoulder to shoulder with our clients, we at QPS like to…
Two companies have just selected QPS Netherlands to conduct their First-in-Human…
An investigation into the efficacy and safety of Estetrol (E4) for…
Patient recruitment is one of the most critical foundations of any…
QPS has been assisting an international Sponsor to perform a global,…
QPS has been assisting an international Sponsor to perform a global,…
The European Medicines Agency (EMA) has released a draft guideline revision…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
Webinars

The Psychedelic Renaissance and the Mysteries of Mind-Altering Medicine
January 22, 2024
Psychiatric treatment is undergoing a profound shift as once-stigmatized psychedelic drugs gain mainstream acceptance. For instance, the Food and Drug Administration (FDA) approved a variant

Early Study Shows Lower Dementia Risk Linked to Shingles Vaccine
July 17, 2023
Adding to research suggesting that vaccines for certain viral diseases may make someone less vulnerable to dementia later in life, a recent study demonstrates an association between

First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
March 6, 2023
Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children living

Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021, the

New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
November 16, 2022
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants who

FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription costs

Hangry Is Officially a Thing. So, What Should We Do About It?
August 8, 2022
In 2018 the word “hangry,” the portmanteau of hungry and angry, was finally added to the Oxford English Dictionary. We say finally because the concept

War in Ukraine Impacts Clinical Research Industry
May 18, 2022
Russia’s invasion of Ukraine is causing what the Financial Times called a “many-sided economic shock,” sending global prices sky-high for goods ranging from fuel to

Using Video Games for Early Detection of Parkinson’s Disease
August 3, 2020
Parkinson’s Disease (PD) is diagnosed based on classical motor symptoms, including bradykinesia (slowed movement and loss of spontaneous movement), muscular rigidity, resting tremors and postural

Working with Families in Pediatric Clinical Drug Trials
October 1, 2019
When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If certain

Guidance for Scheduling Clinical Trials in Children
September 24, 2019
Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved for

New Horizons for Patient Studies at QPS-NL
September 13, 2019
In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug development.
Solutions for Recruitment for Pediatric Clinical Trials
September 3, 2019
Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are often

Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific literature.
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute ischemic
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels along
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success if
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational drug
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly formulated
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…